Recombinant human TNFRSF7/CD27 protein

Cat No.
ATGP3416

Size

QTY

List Price

10ug

USD 77


20ug

USD 142

50ug

USD 189

100ug

USD 313

250ug

USD 549

500ug

USD 938

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
Baculovirus
Domain
21-191aa
UniProt No.
P26842
NCBI Accession No.
NP_001233.1
Alternative names
CD27L receptor, T-cell activation antigen CD27, T14, Tumor necrosis factor receptor superfamily member 7, TNFRSF7, T cell antivation antigen S152, TP55

Product Specification

Molecular Weight
46.4 kDa (413aa)
Concentration
0.5mg/ml (determined by absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 85% by SDS-PAGE
Bioactivity
Measured by its binding ability in a functional ELISA with Human CD27 Ligand/TNFSF7 (CAT# ATGP3336). The ED50 range ≤ 0.5 ug/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
hIgG-His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

Human CD27 Ligand/TNFSF7 (CAT# ATGP3336) is coated at 10 ug/ml (100 ul/well) can bind Human CD27/TNFRSF7. The ED50 range ≤ 0.5 ug/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.